DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Pishvaian MJ, Lee MS, Ryoo B. et al.
Updated safety and clinical activity results from a phase Ib study of atezolizumab+ bevacizumab in hepatocellular carcinoma (HCC).
Ann Oncol 2018;
29 (Suppl. 08) mdy424-mdy028
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.